An Industry Perspective on the Monitoring of Subvisible Particles as a Quality Attribute for Protein Therapeutics

The importance of measuring sub-visible particles and understanding the relationship between protein aggregation and immunogenicity. (requires purchase)

This article by S. Singh, et al. in Journal of Pharmaceutical Sciences, 99 (8) 3302-3321, (August 2010) is available for purchase – free to members of American Pharmacists Association (APhA)

Please Signup/Login to see the full article.